Belgium's independent federal research centre that advises policymakers on health care and health insurance, including health technology assessment. Set up in 2003, it advises but does not decide.
The KCE describes itself as an independent research centre that gives scientific advice on health care to policymakers, on topics generally submitted by the authorities, including the Minister and Ministry of Public Health and RIZIV-INAMI, and by universities and professional associations. It was established in 2003, after the idea arose in 2002 in the cabinet of the then Minister of Social Affairs, Frank Vandenbroucke, and published its first reports in 2004; it names NICE, the Haute Autorité de Santé and the Zorginstituut Nederland as comparable bodies. It states that it is strictly advisory and not involved in decisions, so decision-makers may choose not to follow its recommendations, and that as a type B parastatal body it has a high degree of independence from the federal authorities that fund it.
Its management page names Ann Van den Bruel as general director. The national insurer cites its 2015 report on better managed off-label use of medicines on the page that explains the temporary reimbursement of unlicensed medicines for children with cancer, and the Belgian Cancer Registry lists it among the partners it works with.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-11-19.
Matched to Belgian Health Care Knowledge Centre (KCE), including child institutions. 22 works · 42 citations · 100% open access · 5% clinical trials · 0% reviews.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/